PRIME Time: SMEs In Focus As EMA Launches Priority Medicines Scheme
This article was originally published in SRA
Executive Summary
The EMA has confirmed that while its new PRIME (priority medicines) scheme, which was officially launched on March 7, will be open to companies of all sizes, it is expected to be of particular value to smaller companies and academics, whose eligibility for earlier access to the scheme has been written more firmly into the PRIME guidelines just published on the EMA website.